2026. Dose Optimization of Sacubitril/Valsartan and Its Impact on Clinical Outcomes in Heart Failure with Reduced Ejection Fraction: A Systematic Review . Journal of Pharmaceutical and Sciences. 9, 4 (Oct. 2026), 3203–3217. DOI:https://doi.org/10.36490/journal-jps.com.v9i4.1898.